LS-SCLC
Showing 1 - 25 of 522
Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for
Not yet recruiting
- Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Tifcemalimab injection
- +3 more
-
Jinan, Shandong, ChinaShandong Cancer Hospital & Institute
Oct 18, 2023
Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined
Not yet recruiting
- Lung Neoplasms
- Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
- Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
- (no location specified)
Jun 12, 2023
Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Sugemalimab
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 12, 2022
Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)
Recruiting
- Limited Stage Small Cell Lung Cancer
-
Shanghai, Shanghai, China
- +1 more
Jul 29, 2022
SCLC Trial in Shanghai (Conventionally fractionated concurrent chemo-radiotherapy, Accelerated hypofractionated concurrent
Recruiting
- SCLC
- Conventionally fractionated concurrent chemo-radiotherapy
- Accelerated hypofractionated concurrent chemo-radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 26, 2021
Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique
Completed
- Non-small Cell Lung Carcinoma
- Small Cell Lung Carcinoma
- Contralateral Esophageal Sparing Technique (CEST)
-
Boston, Massachusetts
- +1 more
Dec 8, 2021
Small-cell Lung Cancer Trial in Changchun (SHR-1316; Carboplatin; Etoposide;Radiotherapy, Palcebo; Carboplatin;
Enrolling by invitation
- Small-cell Lung Cancer
- SHR-1316; Carboplatin; Etoposide;Radiotherapy
- Palcebo; Carboplatin; Etoposide;Radiotherapy
-
Changchun, Jilin, ChinaJilin Cancer Hospital
Feb 24, 2021
Limited-stage Small Cell Lung Cancer, LS-SCLC Trial (SHR-1316)
Not yet recruiting
- Limited-stage Small Cell Lung Cancer, LS-SCLC
- (no location specified)
Nov 27, 2020
Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
- Tarlatamab
- Placebo
-
Minneapolis, Minnesota
- +124 more
Oct 31, 2023
Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)
Recruiting
- Small Cell Lung Cancer
- Pembrolizumab 200 mg
- +8 more
-
Chandler, Arizona
- +170 more
Feb 2, 2023
Limited Stage Small Cell Lung Cancer Trial in Jinan (MRI Surveillance, Prophylactic Cranial Irradiation)
Recruiting
- Limited Stage Small Cell Lung Cancer
- MRI Surveillance
- Prophylactic Cranial Irradiation
-
Jinan, Shandong, China
- +1 more
Apr 28, 2021
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Japan, United
Recruiting
- Limited Stage Lung Small Cell Carcinoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +544 more
Aug 24, 2022
Small-cell Lung Cancer Trial in Shanghai (TQB2450)
Recruiting
- Small-cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jan 25, 2021
SCLC, Brain Metastases Trial in Heidelberg (SRS, WBRT)
Recruiting
- SCLC
- Brain Metastases
- SRS
- WBRT
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Department of Radiation Oncol
Sep 28, 2021
Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer Trial in Worldwide (Prophylactic cranial
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Extensive-stage Small-cell Lung Cancer
- Prophylactic cranial irradiation
-
Graz, Austria
- +37 more
Jun 8, 2022
Small Cell Lung Cancer, SCLC Trial in Worldwide (Pembrolizumab, Normal saline solution, Carboplatin)
Completed
- Small Cell Lung Cancer (SCLC)
- Pembrolizumab
- +4 more
-
Miami, Florida
- +147 more
Sep 2, 2022
Competence Trial in Stockholm (Live Supervision + Session Goal Formulation, Session Goal Formulation)
Active, not recruiting
- Competence
- Live Supervision + Session Goal Formulation
- Session Goal Formulation
-
Stockholm, Region Stockholm, SwedenKarolinska Institute
Nov 3, 2022
Microbiome in Postmenopausal Women With Vulvar Lichen Sclerosus
Recruiting
- Vulvar Lichen Sclerosus
-
Dallas, TexasUT Southwestern Medical Center
Jul 26, 2022
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer
Recruiting
- SCLC,Extensive Stage
- PD-(L)1 antibody immunotherapy
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
Jul 3, 2023
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023